Economic impact of mepolizumab in uncontrolled severe eosinophilic asthma, in real life()

BACKGROUND AND AIMS: Severe asthma is burdened by frequent exacerbations and use of oral corticosteroids (OCS) which worsen patients’ health and increase healthcare spending. Aim of this study was to assess the clinical and economic effect of adding mepolizumab (MEP) for the treatment of these patie...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:World Allergy Organ J
Hlavní autoři: Bagnasco, Diego, Povero, Massimiliano, Pradelli, Lorenzo, Brussino, Luisa, Rolla, Giovanni, Caminati, Marco, Menzella, Francesco, Heffler, Enrico, Canonica, Giorgio Walter, Paggiaro, Pierluigi, Senna, Gianenrico, Milanese, Manlio, Lombardi, Carlo, Bucca, Caterina, Manfredi, Andrea, Canevari, Rikki Frank, Passalacqua, Giovanni
Médium: Artigo
Jazyk:Inglês
Vydáno: World Allergy Organization 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7846931/
https://ncbi.nlm.nih.gov/pubmed/33598095
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.waojou.2021.100509
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky